
Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 29, 2021, titled "Pharma Majors Collaborate for Clinical Trial of Investigational Oral Anti-Viral Drug Molnupiravir for COVID-19".
Filed with NSE ·
Watch Dr. Reddy's Laboratories' latest callDr. Reddy's Laboratories (NSE:DRREDDY) Q1 2027 Earnings Call · Replay · Jul 22Read the transcript of Dr. Reddy's Laboratories (NSE:DRREDDY) Q1 2027 Earnings Call
Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 29, 2021, titled "Pharma Majors Collaborate for Clinical Trial of Investigational Oral Anti-Viral Drug Molnupiravir for COVID-19".
6ix hasn’t read this filing yet.
Dr. Reddy's Laboratories Ltd. on 6ix
Follow Dr. Reddy's Laboratories into a list and get an email when it puts out news.
Follow Dr. Reddy's Laboratories